LanZhou Foci Pharmaceutical Co.,Ltd. (SHE:002644)
China
· Delayed Price · Currency is CNY 9.15
+0.24 (2.69%)
At close: Mar 10, 2026
SHE:002644 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 4,673 | 3,942 | 4,979 | 4,764 | 5,127 | 3,615 | Upgrade
|
| Market Cap Growth | 14.23% | -20.82% | 4.50% | -7.07% | 41.81% | -3.80% | Upgrade
|
| Enterprise Value | 4,280 | 3,655 | 4,750 | 4,553 | 4,850 | 3,347 | Upgrade
|
| Last Close Price | 9.15 | 7.71 | 9.69 | 9.23 | 9.92 | 6.91 | Upgrade
|
| PE Ratio | 79.08 | 65.63 | 74.10 | 43.85 | 54.98 | 33.47 | Upgrade
|
| Forward PE | - | 85.11 | 85.11 | 85.11 | 85.11 | 85.11 | Upgrade
|
| PS Ratio | 5.22 | 4.02 | 4.28 | 4.57 | 6.27 | 5.41 | Upgrade
|
| PB Ratio | 2.53 | 2.17 | 2.82 | 2.74 | 3.15 | 2.28 | Upgrade
|
| P/TBV Ratio | 2.69 | 2.31 | 3.01 | 2.92 | 3.33 | 2.40 | Upgrade
|
| P/FCF Ratio | 35.30 | 153.42 | 115.14 | 105.68 | - | - | Upgrade
|
| P/OCF Ratio | 31.43 | 101.12 | 75.77 | 55.01 | 432.49 | 57.49 | Upgrade
|
| EV/Sales Ratio | 4.78 | 3.73 | 4.08 | 4.37 | 5.93 | 5.01 | Upgrade
|
| EV/EBITDA Ratio | 46.46 | 38.98 | 41.56 | 39.61 | 51.83 | 57.29 | Upgrade
|
| EV/EBIT Ratio | 101.34 | 82.82 | 75.52 | 68.88 | 106.24 | 251.95 | Upgrade
|
| EV/FCF Ratio | 32.33 | 142.24 | 109.85 | 101.00 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.02 | 0.02 | 0.03 | 0.03 | 0.04 | 0.06 | Upgrade
|
| Debt / EBITDA Ratio | 0.35 | 0.43 | 0.46 | 0.48 | 0.73 | 1.72 | Upgrade
|
| Debt / FCF Ratio | 0.24 | 1.59 | 1.22 | 1.23 | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.23 | -0.20 | -0.20 | -0.20 | -0.19 | -0.22 | Upgrade
|
| Net Debt / EBITDA Ratio | -4.60 | -3.81 | -3.09 | -2.99 | -3.27 | -6.02 | Upgrade
|
| Net Debt / FCF Ratio | -3.15 | -13.90 | -8.17 | -7.64 | 14.62 | 5.89 | Upgrade
|
| Asset Turnover | 0.36 | 0.39 | 0.45 | 0.42 | 0.35 | 0.28 | Upgrade
|
| Inventory Turnover | 1.67 | 1.92 | 2.19 | 2.37 | 2.31 | 1.85 | Upgrade
|
| Quick Ratio | 2.21 | 2.26 | 1.79 | 1.66 | 1.95 | 1.82 | Upgrade
|
| Current Ratio | 3.10 | 3.22 | 2.65 | 2.40 | 2.76 | 2.50 | Upgrade
|
| Return on Equity (ROE) | 3.21% | 3.44% | 3.88% | 6.49% | 5.82% | 6.95% | Upgrade
|
| Return on Assets (ROA) | 1.06% | 1.10% | 1.53% | 1.67% | 1.20% | 0.35% | Upgrade
|
| Return on Invested Capital (ROIC) | 2.57% | 2.74% | 3.73% | 4.07% | 3.01% | 0.91% | Upgrade
|
| Return on Capital Employed (ROCE) | 2.00% | 2.10% | 3.10% | 3.20% | 2.30% | 0.70% | Upgrade
|
| Earnings Yield | 1.26% | 1.52% | 1.35% | 2.28% | 1.82% | 2.99% | Upgrade
|
| FCF Yield | 2.83% | 0.65% | 0.87% | 0.95% | -0.41% | -1.65% | Upgrade
|
| Dividend Yield | 0.13% | 0.16% | 0.31% | 0.54% | 0.10% | 1.74% | Upgrade
|
| Payout Ratio | 12.96% | 26.56% | 41.59% | 6.53% | 65.88% | 28.37% | Upgrade
|
| Buyback Yield / Dilution | 0.03% | -0.05% | 0.01% | 0.03% | -0.00% | -0.03% | Upgrade
|
| Total Shareholder Return | 0.17% | 0.11% | 0.32% | 0.57% | 0.10% | 1.71% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.